2025-02-22T16:40:59-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: Query fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-137633%22&qt=morelikethis&rows=5
2025-02-22T16:40:59-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: => GET http://localhost:8983/solr/biblio/select?fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-137633%22&qt=morelikethis&rows=5
2025-02-22T16:40:59-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: <= 200 OK
2025-02-22T16:40:59-05:00 DEBUG: Deserialized SOLR response

Experimental study of liposomal docetaxel analysis of docetaxel incorporation and stability

Aim: The article presents the results of developing the composition and technology of obtaining the liposomal form of docetaxel. The effect of the phospholipid composition of the membrane, ionic strength, pH, temperature, cryoprotectant type, and other factors on the stability of liposomes and the d...

Full description

Saved in:
Bibliographic Details
Main Authors: Krasnopolsky, Y.M., Dudnichenko, A.S.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2017
Series:Experimental Oncology
Subjects:
Online Access:http://dspace.nbuv.gov.ua/handle/123456789/137633
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim: The article presents the results of developing the composition and technology of obtaining the liposomal form of docetaxel. The effect of the phospholipid composition of the membrane, ionic strength, pH, temperature, cryoprotectant type, and other factors on the stability of liposomes and the docetaxel incorporation has been considered. Results: Reduction of toxicity of the liposomal form of docetaxel (LD₅₀ — 137 ± 7.7 mg/kg) was found in comparison with its free form (LD₅₀ — 101 ± 6.3 mg/kg). Preservation of nanosize particle after lyophilization has been shown. Conclusions: As a result of the studies, the optimal composition and technological scheme for obtaining liposomes containing docetaxel have been developed allowing large-scale production of docetaxel in liposomal form.